Cargando…
Beneficial Role of Rosuvastatin in Blood–Brain Barrier Damage Following Experimental Ischemic Stroke
Hemorrhage transformation is the most challenging preventable complication in thrombolytic therapy and is related to recombinant tissue plasminogen activator (rt-PA)-induced blood–brain barrier (BBB) damage. Intraperitoneal injections of normal or high doses of rosuvastatin were administered to Balb...
Autores principales: | Lu, Dan, Mai, Hong-Cheng, Liang, Yu-Bin, Xu, Bing-Dong, Xu, An-Ding, Zhang, Yu-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110873/ https://www.ncbi.nlm.nih.gov/pubmed/30186167 http://dx.doi.org/10.3389/fphar.2018.00926 |
Ejemplares similares
-
S1PR3, as a Core Protein Related to Ischemic Stroke, is Involved in the Regulation of Blood–Brain Barrier Damage
por: Fan, Xuehui, et al.
Publicado: (2022) -
Perlecan and the Blood-Brain Barrier: Beneficial Proteolysis?
por: Roberts, Jill, et al.
Publicado: (2012) -
Synergic Neuroprotection Between Ligusticum Chuanxiong Hort and Borneol Against Ischemic Stroke by Neurogenesis via Modulating Reactive Astrogliosis and Maintaining the Blood–Brain Barrier
por: Yu, Bin, et al.
Publicado: (2021) -
Effect and Safety of Rosuvastatin in Acute Ischemic Stroke
por: Heo, Ji Hoe, et al.
Publicado: (2016) -
Storax Inhibits Caveolae-Mediated Transcytosis at Blood-Brain Barrier After Ischemic Stroke in Rats
por: Zhou, Min, et al.
Publicado: (2022)